• Research and Development

  Compound from Chinese Plant Reverses Fibrosis in Rat Model Study

  Posted by Pulmonary Fibrosis News Moderator on July 23, 2018 at 2:56 pm

  Astragaloside IV — a compound isolated from a traditional Chinese medicinal plant — was found to reverse epithelial–mesenchymal transition, a process crucial to the progression of fibrosis, through its impact on a protein called FOXO3a, a study in a rat IPF model reports.

  Click here to read more about the promise of this compound for treating people with pulmonary fibrosis.

  
  Astragaloside IV is isolated from the traditional Chinese medicinal plant called astragalus membranaceus. Are you using any other traditional Chinese approaches as part of your treatment plan?

  replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply